http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-8405275-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7b1da85d93179550ad9723c50e07466
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-523
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-542
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0283
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-42
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-116
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 1982-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1984-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-8405275-A1
titleOfInvention "A PROCEDURE FOR PREPARING AN ORAL VACCINE FOR IMMUNIZATION AGAINST ENTERIC DISEASES".
abstract METHOD OF PRODUCING AN ATTENUATED ORAL VACCINE FOR IMMUNIZATION AGAINST ENTERIC DISEASES. IT INCLUDES THE OPERATIONS OF: A) PREPARING A LAYER OF ATTENUATED SALMONELLA TYPHI, GALACTOSE WITHOUT EPIMERASE, TREATED BY GENETIC ENGINEERING TO CARRY THE GENETIC DETERMINANTS OF ADDITIONAL PROTECTIVE ANTIGENS, INCLUDING AT LEAST A SHIGELLA STRAIN, SUCH AS S. SONNEI, S. FLEXNENI, S. DY SENTERIAE AND S. BOYDII; B) PAIRING IN A CONJUGATE WAY THE ATTENUATED SALMONELLA TYPHI STRAIN; C) ISOLATE AND PURIFY A RESULTING CLONE EXPRESSED BY THE ANTIGEN OF S. TYPHI AND WHICH ALSO EXPRESSES THE ANTIGEN OF THE SHIGELLA STRAIN; AND D) FORMING AN ORAL VACCINE BY DISPENSING THE GENETICALLY ENGINEERED CLONIC CELLS IN A LIQUID OR SOLID DILUENT, SUCH AS A TABLET OR CAPSULE.
priorityDate 1981-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588234

Total number of triples: 29.